However, the activation of FXR by its agonists CDCA and GW4064 could lead to enhanced (TGF)-β-induced epithelial-mesenchymal transition (EMT) in HCC cells, implying its potential in promoting tumor metastasis [86]. This evidence concerns the gene NR1H4 and hepatocellular carcinoma.